Study provides a more accurate tool to stratify patients with HER2-positive breast ca

[News]

Patients with a type of breast cancer called HER2-positive are less likely to survive if their initial treatment fails to eradicate the tumor completely and they have high levels of immune cells called tumor-infiltrating lymphocytes in the residual disease.

More... (https://www.news-medical.net/news/20221121/Study-provides-a-more-accurate-tool-to-stratify-patients-with-HER2-positive-breast-cancer.aspx)